SCHEMBL5147104

SCHEMBL5147104

N=C(NO)c1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Br)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.48
HDAC6 Q9UBN7 9/20 0.48
HDAC10 Q969S8 1/20 0.35
TP53 P04637 1/20 0.35
CREBBP Q92793 1/20 0.35
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
MAPT P10636 2/20 0.31
MAPK1 P28482 1/20 0.31
RXRA P19793 1/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 2/20 0.31
HPGD P15428 2/20 0.31
RECQL P46063 2/20 0.31
BLM P54132 2/20 0.31
KMT2A Q03164 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147102 0.86 HDAC1 (0.48) HDAC1HDAC6HDAC10TP53CREBBP
SCHEMBL5147159 0.85 HDAC1 (0.45) HDAC1HDAC6HDAC10TP53CREBBP
SCHEMBL4768273 0.79 HDAC1 (0.42) HDAC1HDAC6HDAC10TP53CREBBP
SCHEMBL4768253 0.77 HDAC1 (0.44) HDAC1HDAC6HDAC10TP53CREBBP
SCHEMBL5147071 0.77 HDAC1 (0.39) HDAC1HDAC6TP53CREBBPCSNK2B
SCHEMBL4768263 0.75 HDAC1 (0.45) HDAC1HDAC6HDAC10TP53CREBBP
SCHEMBL5145477 0.75 HDAC1 (0.46) HDAC1HDAC6TP53CREBBPPTGS1
SCHEMBL14422435 0.74 HDAC1 (0.43) HDAC1HDAC6TP53CREBBPPTGS1
SCHEMBL1219389 0.73 MEN1 (0.33) HDAC1HDAC6MAPTMEN1ALDH1A1
SCHEMBL5147078 0.73 HDAC1 (0.48) HDAC1HDAC6HDAC10TP53CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885HDAC10 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.